Vaishali Pharma [VAISHALI] vs Aarey Drugs [AAREYDRUGS] Detailed Stock Comparison

Vaishali Pharma

NSE
Loading...

Aarey Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Vaishali Pharma wins in 5 metrics, Aarey Drugs wins in 13 metrics, with 0 ties. Aarey Drugs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVaishali PharmaAarey DrugsBetter
P/E Ratio (TTM)187.3356.32Aarey Drugs
Price-to-Book Ratio2.341.67Aarey Drugs
Debt-to-Equity Ratio18.9825.17Vaishali Pharma
PEG RatioN/A6.19N/A
EV/EBITDA-181.0784.42Vaishali Pharma
Profit Margin (TTM)0.38%0.93%Aarey Drugs
Operating Margin (TTM)5.16%1.19%Vaishali Pharma
EBITDA Margin (TTM)5.16%1.19%Vaishali Pharma
Return on Equity1.26%2.91%Aarey Drugs
Return on Assets (TTM)0.74%1.39%Aarey Drugs
Free Cash Flow (TTM)$-183.43M$50.96MAarey Drugs
1-Year Return-46.57%34.87%Aarey Drugs
Price-to-Sales Ratio (TTM)1.400.52Aarey Drugs
Enterprise Value$1.54B$2.38BAarey Drugs
EV/Revenue Ratio1.470.53Aarey Drugs
Gross Profit Margin (TTM)1.47%4.28%Aarey Drugs
Revenue per Share (TTM)$8$160Aarey Drugs
Earnings per Share (Diluted)$0.06$1.46Aarey Drugs
Beta (Stock Volatility)0.270.52Vaishali Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vaishali Pharma vs Aarey Drugs Stock Performance Analysis

Loading Price Chart...

Vaishali Pharma
Aarey Drugs
Vaishali Pharma Stock Overview | Aarey Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vaishali Pharma-1.23%-1.13%-7.94%-3.73%-7.56%-36.20%
Aarey Drugs0.18%3.79%17.75%18.15%85.18%45.78%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vaishali Pharma-46.57%15.90%204.01%168.79%168.79%168.79%
Aarey Drugs34.87%111.74%93.43%93.43%93.43%93.43%

News Based Sentiment: Vaishali Pharma vs Aarey Drugs

Vaishali Pharma

News based Sentiment: NEGATIVE

October was a difficult month for Vaishali Pharma, with declining income, concerning financial ratios, and a negative analyst outlook. While there were some positive price movements and a bulk deal, the overall trend suggests increased risk and warrants investor caution. The combination of these factors makes this a significant month for the company's investment story.

View Vaishali Pharma News Sentiment Analysis

Aarey Drugs

News based Sentiment: POSITIVE

October was a strong month for Aarey Drugs & Pharmaceuticals, marked by a new 52-week high, significant gains over the past six months, and positive overall growth trends. While there was some daily volatility, the overall narrative is one of positive momentum and investor confidence.

View Aarey Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Vaishali Pharma vs Aarey Drugs

MetricVAISHALIAAREYDRUGS
Market Information
Market Cap i₹1.51B₹2.34B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i270,98781,388
90 Day Avg. Volume i348,97454,682
Last Close₹11.23₹84.00
52 Week Range₹10.30 - ₹24.91₹32.85 - ₹84.00
% from 52W High-54.92%0.00%
All-Time High₹24.91 (Oct 14, 2024)₹84.00 (Oct 07, 2025)
% from All-Time High-54.92%0.00%
Growth Metrics
Quarterly Revenue Growth0.31%-0.20%
Quarterly Earnings Growth-0.25%0.11%
Financial Health
Profit Margin (TTM) i0.00%0.01%
Operating Margin (TTM) i0.05%0.01%
Return on Equity (TTM) i0.01%0.03%
Debt to Equity (MRQ) i18.9825.17
Cash & Liquidity
Book Value per Share (MRQ)₹4.79₹49.36
Cash per Share (MRQ)₹0.14₹1.29
Operating Cash Flow (TTM) i₹-326,443,000₹366.06M
Levered Free Cash Flow (TTM) i₹8.17M₹40.24M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Vaishali Pharma vs Aarey Drugs

MetricVAISHALIAAREYDRUGS
Price Ratios
P/E Ratio (TTM) i187.3356.32
Forward P/E iN/AN/A
PEG Ratio iN/A6.19
Price to Sales (TTM) i1.400.52
Price to Book (MRQ) i2.341.67
Market Capitalization
Market Capitalization i₹1.51B₹2.34B
Enterprise Value i₹1.54B₹2.38B
Enterprise Value Metrics
Enterprise to Revenue i1.470.53
Enterprise to EBITDA i-181.0784.42
Risk & Other Metrics
Beta i0.270.52
Book Value per Share (MRQ) i₹4.79₹49.36

Financial Statements Comparison: Vaishali Pharma vs Aarey Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VAISHALIAAREYDRUGS
Revenue/Sales i₹311.02M₹1.02B
Cost of Goods Sold i₹306.45M₹978.36M
Gross Profit i₹4.58M₹43.73M
Research & Development iN/AN/A
Operating Income (EBIT) i₹1.33M₹12.17M
EBITDA i₹9.89M₹32.54M
Pre-Tax Income i₹-56.02M₹17.28M
Income Tax i₹-13.10M₹3.57M
Net Income (Profit) i₹-42.93M₹13.71M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VAISHALIAAREYDRUGS
Cash & Equivalents i₹17.11M₹14.73M
Total Current Assets i₹1.04B₹2.66B
Total Current Liabilities i₹400.53M₹1.49B
Long-Term Debt i₹46.19M₹19.87M
Total Shareholders Equity i₹649.16M₹1.38B
Retained Earnings i₹157.29M₹571.32M
Property, Plant & Equipment i₹0₹1.96M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VAISHALIAAREYDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVAISHALIAAREYDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i270,98781,388
Average Daily Volume (90 Day) i348,97454,682
Shares Outstanding i130.46M28.45M
Float Shares i74.91M9.96M
% Held by Insiders iN/A0.51%
% Held by Institutions iN/A0.02%

Dividend Analysis & Yield Comparison: Vaishali Pharma vs Aarey Drugs

MetricVAISHALIAAREYDRUGS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A